Roivant Sciences (ROIV) Revenue (2020 - 2025)

Roivant Sciences has reported Revenue for 6 years, with the latest figure at $2.0 million in Q4 2025.

• For the quarter ending Q4 2025, Revenue fell 77.83% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2025 stood at $14.8 million (down 60.16% YoY), and the FY2026 full-year result was $8.3 million, down 71.57% from the prior year.
• Revenue for Q4 2025 stood at $2.0 million, up from $1.6 million in the prior quarter.
• The five-year high for Revenue was $24.3 million in Q4 2021, with the low at $1.6 million in Q3 2025.
• Historically, Revenue has averaged $9.9 million across 5 years, with a median of $8.0 million in 2024.
• Annual changes were most pronounced in 2021 — Revenue surged 957.22% — and 2025, when it slumped 77.83%.
• Roivant Sciences' Revenue stood at $24.3 million in 2021, then slipped by 29.95% to $17.1 million in 2022, then fell by 8.74% to $15.6 million in 2023, then tumbled by 42.05% to $9.0 million in 2024, then tumbled by 77.83% to $2.0 million in 2025.
• The last three Revenue figures came in at $2.0 million (Q4 2025), $1.6 million (Q3 2025), and $2.2 million (Q2 2025), per Business Quant data.